UBS Initiates Coverage On Wave Life Sciences with Buy Rating, Announces Price Target of $11

Benzinga · 2d ago
UBS analyst Joon Lee initiates coverage on Wave Life Sciences (NASDAQ:WVE) with a Buy rating and announces Price Target of $11.